REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 79 filers reported holding REVANCE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.25 and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $274,000 | -86.4% | 10,000 | -84.8% | 0.01% | -86.4% |
Q1 2018 | $2,020,000 | -9.0% | 65,600 | +5.6% | 0.08% | -17.3% |
Q4 2017 | $2,220,000 | +252.4% | 62,100 | +171.2% | 0.10% | +206.2% |
Q3 2017 | $630,000 | +104.5% | 22,900 | +95.7% | 0.03% | +100.0% |
Q2 2017 | $308,000 | -41.4% | 11,700 | -28.9% | 0.02% | -11.1% |
Q2 2015 | $526,000 | – | 16,460 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |